Moderna CEO made more than $18 million in 2021, could receive golden parachute worth nearly $1 billion
Moderna is a biotechnology company that was founded in 2010 and develops medicines based on mRNA technology. Stéphane Bancel – who was previously a top executive at pharmaceutical behemoth Eli Lilly and Company and CEO of French biotech company bioMérieux – was hired as CEO of Moderna in 2011.
Moderna went public in 2018 and raised more than $600 million at its initial public offering, making it the biggest biotechnology IPO at the time.
Moderna, which is based in Cambridge, Massachusetts, brought its first product to market in December 2020, when the Food and Drug Administration gave emergency use authorization to Moderna’s COVID-19 vaccine.
Moderna sold 807 million doses of the company’s COVID-19 vaccine, reported to be worth $17.7 billion – accounting for virtually all of the company’s revenue. In 2021, Moderna’s total revenue was a whopping $18.5 billion, a major increase from 2020’s total revenue of $803 million. Moderna has projected sales of $19 billion for 2022 based on vaccine purchase agreements with governments across the world.- READ MORE
Responses